Document is current
Any future updates will be listed below
-
Authors
Gampenrieder, Simon Peter https://orcid.org/0000-0002-3966-1071
Castagnaviz, Vanessa
-
Funding
Funding for this research was provided by:
Paracelsus Medical University
- License Information
-
More Information
Article History
Received: 19 May 2025
Accepted: 2 July 2025
First Online: 3 September 2025
Conflict of interest
: S.P. Gampenrieder received honoraria from Roche, Daiichi Sankyo, Seagen, Novartis, BMS, AstraZeneca, Pfizer, Janssen, Gilead, Eli Lilly and MSDM; travel support from Roche, Amgen, Novartis, Pfizer, Bayer, Celgene, Daiichi Sankyo, Janssen and Gilead; and research grants from Roche, Daiichi Sankyo, Novartis, Pfizer, Caris Life Sciences, Lilly, Seagen, Gilead, AstraZeneca and Stemline Therapeutics. V. Castagnaviz received honoraria from Daiichi Sankyo, AstraZeneca, Roche, Novartis, Roche, and travel grants from Eli Lilly, Daiichi Sankyo, Gilead, Pfizer, Seagen, AstraZeneca, Roche, Caris Life Science, Pierre Fabre.
